Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results
Written by Emily J. Thompson, Senior Investment Analyst
Source: Benzinga
U.S. Stock Market Performance: U.S. stocks declined this morning, with the Nasdaq Composite dropping over 1%, while Microsoft shares fell around 5% despite reporting strong first-quarter revenue growth.
Global Market Trends: European and Asian markets also experienced losses, with notable declines in major indices, while U.S. economic indicators showed a decrease in initial jobless claims and modest increases in personal income and spending.
Analyst Views on ATEC
Wall Street analysts forecast ATEC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATEC is 23.00 USD with a low forecast of 16.00 USD and a high forecast of 27.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
10 Buy
1 Hold
0 Sell
Strong Buy
Current: 17.460
Low
16.00
Averages
23.00
High
27.00
Current: 17.460
Low
16.00
Averages
23.00
High
27.00
About ATEC
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. The Company's Organic Innovation Machine is focused on developing new approaches that integrate with its expanding Alpha InformatiX (AIX) Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include AIX, positioners, access systems, implants and fixation systems, and biologics. Its AIX product platform comprises its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and its navigation-enabled robotics platform (Valence). It has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
